FOLH1 and neoplasm: In these conditions, PSMA exerts both ligand-induced endocytic transport and glutamate-releasing enzymatic activities (6), the latter being shown to correlate with tumor progression (7) upon activation of mechanisms dependent on the seven-domain transmembrane protein G–coupled metabotropic glutamate receptors (mGluR; refs. 8, 9).